NEXGEL, Inc. (NXGL)

USD 4.23

(-10.19%)

Total Liabilities Summary of NEXGEL, Inc.

  • NEXGEL, Inc.'s latest annual total liabilities in 2023 was 4.78 Million USD , up 76.07% from previous year.
  • NEXGEL, Inc.'s latest quarterly total liabilities in 2024 Q2 was 5.24 Million USD , up 1.33% from previous quarter.
  • NEXGEL, Inc. reported annual total liabilities of 2.72 Million USD in 2022, down -44.47% from previous year.
  • NEXGEL, Inc. reported annual total liabilities of 4.89 Million USD in 2021, up 124.06% from previous year.
  • NEXGEL, Inc. reported quarterly total liabilities of 5.18 Million USD for 2024 Q1, up 8.16% from previous quarter.
  • NEXGEL, Inc. reported quarterly total liabilities of 4.78 Million USD for 2023 Q4, up 29.75% from previous quarter.

Annual Total Liabilities Chart of NEXGEL, Inc. (2023 - 2016)

Historical Annual Total Liabilities of NEXGEL, Inc. (2023 - 2016)

Year Total Liabilities Total Liabilities Growth
2023 4.78 Million USD 76.07%
2022 2.72 Million USD -44.47%
2021 4.89 Million USD 124.06%
2020 2.18 Million USD 44.77%
2019 1.51 Million USD 229.69%
2018 458 Thousand USD 70.26%
2017 269 Thousand USD -42.4%
2016 467 Thousand USD 0.0%

Peer Total Liabilities Comparison of NEXGEL, Inc.

Name Total Liabilities Total Liabilities Difference
Akoya Biosciences, Inc. 126.59 Million USD 96.217%
AngioDynamics, Inc. 112.08 Million USD 95.727%
AtriCure, Inc. 147.76 Million USD 96.759%
Avinger, Inc. 19.97 Million USD 76.021%
Azenta, Inc. 351.22 Million USD 98.636%
BioLife Solutions, Inc. 75.05 Million USD 93.619%
The Cooper Companies, Inc. 4.1 Billion USD 99.883%
Daxor Corporation 858.75 Thousand USD -457.666%
Ekso Bionics Holdings, Inc. 16.31 Million USD 70.641%
Femasys Inc. 9.4 Million USD 49.071%
GlucoTrack, Inc. 1.7 Million USD -180.386%
Harvard Bioscience, Inc. 64.29 Million USD 92.551%
Hologic, Inc. 4.02 Billion USD 99.881%
ICU Medical, Inc. 2.25 Billion USD 99.788%
Intuitive Surgical, Inc. 2.04 Billion USD 99.766%
KORU Medical Systems, Inc. 8.1 Million USD 40.929%
LeMaitre Vascular, Inc. 48.87 Million USD 90.202%
Innovative Eyewear, Inc. 659.93 Thousand USD -625.676%
Innovative Eyewear, Inc. 659.93 Thousand USD -625.676%
Masimo Corporation 1.67 Billion USD 99.714%
Microbot Medical Inc. 3.82 Million USD -25.17%
Meihua International Medical Technologies Co., Ltd. 25.07 Million USD 80.903%
Merit Medical Systems, Inc. 1.12 Billion USD 99.574%
Nephros, Inc. 3.5 Million USD -36.711%
NovoCure Limited 783.63 Million USD 99.389%
NEXGEL, Inc. 4.78 Million USD 0.0%
Singular Genomics Systems, Inc. 86.46 Million USD 94.461%
OraSure Technologies, Inc. 52.17 Million USD 90.821%
Pro-Dex, Inc. 23.34 Million USD 79.484%
Pulse Biosciences, Inc. 16.44 Million USD 70.877%
Predictive Oncology Inc. 6.14 Million USD 22.073%
Precision Optics Corporation, Inc. 6.84 Million USD 30.034%
QuidelOrtho Corporation 3.55 Billion USD 99.865%
Repligen Corporation 853.2 Million USD 99.439%
Sanara MedTech Inc. 29.28 Million USD 83.646%
STAAR Surgical Company 102.73 Million USD 95.339%
Sharps Technology, Inc. 3.85 Million USD -24.229%
Utah Medical Products, Inc. 7.14 Million USD 32.974%
DENTSPLY SIRONA Inc. 4.07 Billion USD 99.883%
Jin Medical International Ltd. 8.92 Million USD 46.338%